Shareholder Urges Taro To Side With Activist's Board Picks

Law360, New York (August 7, 2013, 1:26 PM EDT) -- The Taro Pharmaceuticals Industries Ltd. shareholder that earlier this year helped thwart a takeover urged the company on Wednesday to endorse board nominees proposed by activist investor BlueMountain Capital Management LLC, stoking a battle for control in the leadup to Taro's annual meeting.

New York-based IsZo Capital Management LP, one of Taro's largest minority shareholders with 2 percent of its stock, sent a letter to the Israeli company's board calling for a shakeup that it contends will restore investor faith in Taro and unlock new returns....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.